Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 807 results for "genentech"

Genentech Presents Positive Results From Pivotal Study Of Investigational Immunotherapy Atezolizumab In Specific Type Of Advanced Bladder Cancer At 2015 European Cancer Congress

Genentech Presents Positive Results From Pivotal Study Of Inve...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced early results from a pivotal Phase II study, IMvigor 210, of the investigational cancer immunotherapy atezolizumab (anti-PDL1; MPDL3280A) in people with locally ..., 1 week ago
Business Standard

Patent Office refuses application for Genentech's cancer drug

rk and others filed pre-grant opposition, all parties told patent office they do not want to pursue the case BS Reporter | Chennai September 25, 2015 Last Updated at 16:32 IST The patent office has refused a particular patent application of Genentech Inc, a ...
 Business Standard1 week ago Patent Office refuses patent application for Genentech's cancer drug  Business Standard1 week ago
Medical News Today

Ocrelizumab first investigational medicine to show efficacy in people with primary progressive multiple sclerosis in large Phase III study

Genentech, a member of the Roche Group, has announced positive results from a pivotal Phase III study that evaluated the investigational medicine ocrelizumab in people with primary progressive multiple sclerosis (PPMS). The study (called ORATORIO) ...
San Francisco Chronicle

Drivers who shuttle Genentech workers will get wage increase

Photo: Liz Hafalia / Liz Hafalia / The Chronicle Image 1 of / 1 Caption Close Image 1 of 1 The Genetech parking lot in South San Francisco. Shuttle drivers who transport Genentech employees received a wage increase Thursday, ...
 San Francisco Chronicle1 week ago Tech bus drivers get overdue raises  San Francisco Chronicle.com1 week ago Bus drivers transporting eBay workers will get pay raise  San Francisco Chronicle1 week ago Tech firms respond as drivers negotiate for higher wages  San Francisco Chronicle.com2 weeks ago

Genentech To Present Data From 15 Medicines Across Its Portfolio Of Cancer Immunotherapy And Targeted Medicines During The 2015 European Cancer Congress

Reddit Email Print Reprint Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that data from 138 abstracts will be presented at this year's European Cancer Congress (ECC) from Sept. 25 - 29 in Vienna, ...
 TheStreet.com1 month ago U.S. FDA Grants Breakthrough Therapy Designation For Genentech's Investigational Medicine ACE910 For People With Hemophilia A With Factor VIII Inhibitors  TheStreet.com1 month ago Genentech Haemophilia therapy gets FDA breakthrough designation  Pharmafile1 month ago
Pharma Letter

Genentech's alectinib granted priority review by FDA for non-small-cell lung cancer10-09-2015

Genentech, a unit of Swiss pharma major Roche (SIX: ROG), has been granted priority review by the US Food and Drug Administration for its alectinib for ALK-positive, locally advanced or metastatic non-small-cell lung cancer. The FDA is expected ...
 Pharma Letter3 weeks ago FDA Grants Genentech's Alectinib Priority Review For Specific Type Of ALK-Positive Lung Cancer  TheStreet.com4 weeks ago

What's next for contract workers in tech after the latest shuttle-driver union vote?

Unionization efforts in Silicon Valley notched another win over the weekend when shuttle drivers for Apple, Evernote, Genentech, Yahoo, Zynga and other firms voted unanimously to approve a three-year contract proposed by the Teamsters Union. So ...
 SiliconValley.com2 months ago Tech bus drivers forced to live in cars to make ends meet  San Francisco Chronicle.com2 weeks ago Bus drivers for Apple, others demand $27.50 an hour, new pension plan  iPodDailyNews2 months ago Bus drivers for Apple, Yahoo demand $27.50 an hour  WCVB.com2 months ago
Pharma Letter

AstraZeneca appoints Genentech's Sean Boehn as EVP of global medicines development and CMO

Anglo-Swedish drug major AstraZeneca has appointed Sean Bohen as executive vice president of global medicines… In order to access this content you need to be logged into the site and have an active subscription or trial subscription. Please ...
 Pharma Letter1 month ago AstraZeneca nabs rival's executive  Proactive month ago AstraZeneca names Genentech's Bohen as chief medical officer  4 Traders1 month ago AstraZeneca taps Genetech's Bohen as its chief medical officer  Bio Spectrum Asia1 month ago

Genentech Waste Workers Vote to Join Teamsters Local 853

Workers with Genentech Contractor Clean Harbors Win Teamsters Representation; Among the Latest to Join the Union in Silicon Valley SAN LEANDRO, Calif. , Aug. 5, 2015 /PRNewswire-USNewswire/ -- Workers who collect waste materials for Genentech ...
 WorldNetDaily2 months ago
Tech Times

Experimental Drug Ocrelizumab Proves Successful Against Hard-To-Treat Type Of Multiple Sclerosis

Genentech, a subsidiary of Swiss drug maker Roche, report that its new drug ocrelizumab has yielded positive results in addressing primary progressive multiple sclerosis during the final stage of its clinical trial. (Photo : Dan Kitwood | ) ...
 Tech Times1 week ago FDA Supports Hemophilia A treatment ACE910 Pulse Headlines  NewsListOnline1 month ago Roche hemophilia drug wins fast-track FDA designation  Uncova1 month ago New Roche Drug Shows Promise In Treating 2 Common Types Of Multiple Sclerosis  International Business Times1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - genentech
Get updated on latest news & your favorite topics right in your inbox!
More     Less